---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-191487"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T14:12:26.662160+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ResMed Q4 revenue $1.22B (+9% YoY); EPS $1.98; dividend up 10% to $0.53

## Summary
- Q4 FY2024 revenue $1,223.2M (+9% YoY, +10% constant currency); gross margin 58.5% (+350 bps).
- GAAP diluted EPS $1.98 (+27% YoY); non-GAAP diluted EPS $2.08 (+30% YoY).
- Operating cash flow $440M; debt repayments of $300M in Q4; FY2024 operating cash flow $1.4B.
- Quarterly dividend increased 10% to $0.53 per share (payable Sept 19, record Aug 15).
- Investor Day announced for September 30, 2024.

## SEC filing metadata
- accession: 0001193125-24-191487
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312524191487/0001193125-24-191487-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312524191487/d805836d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-191487
- JSON: https://secwatch.observer/filing/0001193125-24-191487.json
- Plain text: https://secwatch.observer/filing/0001193125-24-191487.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.